NO20054777L - Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelser - Google Patents
Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelserInfo
- Publication number
- NO20054777L NO20054777L NO20054777A NO20054777A NO20054777L NO 20054777 L NO20054777 L NO 20054777L NO 20054777 A NO20054777 A NO 20054777A NO 20054777 A NO20054777 A NO 20054777A NO 20054777 L NO20054777 L NO 20054777L
- Authority
- NO
- Norway
- Prior art keywords
- agent
- pharmaceutical composition
- fluid
- antibacterial agent
- otite
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45620103P | 2003-03-20 | 2003-03-20 | |
PCT/IB2004/000802 WO2004082719A1 (en) | 2003-03-20 | 2004-03-10 | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20054777L true NO20054777L (no) | 2005-10-17 |
Family
ID=33030090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054777A NO20054777L (no) | 2003-03-20 | 2005-10-17 | Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelser |
Country Status (19)
Country | Link |
---|---|
US (1) | US20040214753A1 (zh) |
EP (1) | EP1608406A1 (zh) |
JP (1) | JP2006520778A (zh) |
KR (1) | KR100765614B1 (zh) |
CN (1) | CN1761486A (zh) |
AR (1) | AR043651A1 (zh) |
AU (1) | AU2004222518A1 (zh) |
BR (1) | BRPI0408559A (zh) |
CA (1) | CA2519589A1 (zh) |
CL (1) | CL2004000471A1 (zh) |
CO (1) | CO5611165A2 (zh) |
MX (1) | MXPA05010019A (zh) |
NO (1) | NO20054777L (zh) |
NZ (1) | NZ541780A (zh) |
RU (1) | RU2321423C2 (zh) |
TW (1) | TWI265809B (zh) |
UY (1) | UY28236A1 (zh) |
WO (1) | WO2004082719A1 (zh) |
ZA (1) | ZA200506531B (zh) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US20070082820A1 (en) * | 2002-12-02 | 2007-04-12 | Fred Busch | Composition and Method for Treating Plant Fungal Disease |
BRPI0408099B1 (pt) * | 2003-03-05 | 2014-04-08 | Byocoat Entpr Inc | Solução antimicrobiana e processo |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
EP1740214B1 (en) * | 2004-04-22 | 2007-10-03 | Pfizer Products Incorporated | Method of stabilizing disordered cefovecin sodium salt |
DE102004021281A1 (de) * | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
US7854943B2 (en) * | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US7618651B2 (en) * | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
AT501376B1 (de) * | 2005-01-17 | 2010-11-15 | Pregenzer Bruno | Glucokortikoid-hältiges arzneimittel |
JP2009510007A (ja) * | 2005-09-30 | 2009-03-12 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | メロキシカムを含む医薬調製 |
US7993675B2 (en) | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
US20070264296A1 (en) * | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
US7959943B2 (en) | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
US7976873B2 (en) | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
WO2008035370A2 (en) * | 2006-07-10 | 2008-03-27 | Advanced Enzyme Technologies Limited | Compositions for prevention and treatment of mastitis and metritis |
US8088095B2 (en) | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
EP2120908B1 (en) * | 2007-02-08 | 2017-01-25 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use |
BRPI0700969A (pt) * | 2007-03-22 | 2008-11-04 | Ouro Fino Participacoes E Empr | composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia |
US20100298386A1 (en) * | 2007-10-03 | 2010-11-25 | Burwell Steven R | Compositions and methods for treating mastitis |
RU2513142C2 (ru) | 2008-06-12 | 2014-04-20 | Медтроник Ксомед Инк. | Способ лечения хронических ран |
US8318817B2 (en) * | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
EP2346324A4 (en) | 2008-10-06 | 2012-10-10 | Microbial Defense Systems Llc | ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING |
CN101953784B (zh) * | 2009-07-16 | 2012-02-08 | 中国农业大学 | 含阿莫西林、硫酸粘菌素和泼尼松龙的兽用混悬液及其制备方法 |
CN102647971B (zh) | 2009-10-12 | 2016-03-16 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 用于包含美洛昔康的组合物的容器 |
AU2010347598B2 (en) | 2010-03-03 | 2014-11-27 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
AU2012253476B2 (en) | 2011-05-10 | 2015-09-24 | Next Science IP Holdings Pty Ltd | Antimicrobial solid and methods of making and using same |
BRPI1103782A2 (pt) * | 2011-08-19 | 2013-07-30 | Eurofarma Lab Ltda | produto veterinÁrio para tratamento de mastite, pre composiÇço antibiàtica a anti inflamatària, kit, mÉtodo de preparaÇço uso e mÉtodo de tratamento de mastite |
CN102784161A (zh) * | 2012-08-01 | 2012-11-21 | 张吉川 | 一种治疗急慢性中耳炎的特效滴耳液 |
WO2015023675A2 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
JP2017531026A (ja) | 2014-10-20 | 2017-10-19 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 徐放性乱用抑止性液体充填剤形 |
CN104825474B (zh) * | 2015-04-30 | 2018-02-06 | 中国农业科学院兰州畜牧与兽药研究所 | 一种治疗动物体表损伤的药物组方及其制备工艺 |
CN107530277A (zh) * | 2015-05-06 | 2018-01-02 | 硕腾服务有限责任公司 | 具有轻度粘附的水凝胶制剂 |
US10434097B1 (en) | 2015-09-14 | 2019-10-08 | Gateway Biotechnology, Inc. | Methods and compositions for treating hearing disorders |
ES2755815T3 (es) | 2016-09-13 | 2020-04-23 | Allergan Inc | Composiciones de toxina de Clostridium no proteicas estabilizadas |
CN107252441A (zh) * | 2017-08-07 | 2017-10-17 | 咸阳职业技术学院 | 一种治疗奶牛乳腺炎的药物组合物及其制备方法 |
WO2019126783A1 (en) * | 2017-12-22 | 2019-06-27 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
MX2021010689A (es) * | 2019-03-06 | 2021-10-01 | Zoetis Services Llc | Formulaciones inyectables listas para usar. |
JP2022546036A (ja) * | 2019-08-27 | 2022-11-02 | ケーアイ ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー | 疼痛治療に有用な化合物 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636194A (en) * | 1969-10-23 | 1972-01-18 | Douglas G Parizeau | Composition and method for treating mastitis with therapeutic agents |
DE2063896A1 (de) * | 1970-12-28 | 1972-07-20 | Dynamit Nobel Ag, 5210 Troisdorf | Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung |
ES2079994B1 (es) * | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
CN1174970C (zh) * | 1995-05-25 | 2004-11-10 | G·D·瑟尔公司 | 3-卤代烷基-1h-吡唑的制备方法 |
AU708540B2 (en) * | 1995-06-06 | 1999-08-05 | Bayer Intellectual Property Gmbh | Non-irritation, nonsensitizing, non-ototoxic otic anti-bacterial compositions |
US5756529A (en) * | 1995-09-29 | 1998-05-26 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies |
AP9700912A0 (en) * | 1996-01-11 | 1997-01-31 | Smithkline Beecham Corp | Novel cycloalkyl substituted imidazoles |
DE69739003D1 (de) * | 1996-04-12 | 2008-10-30 | Searle Llc | Substituierte Benzensulfonamid-Derivate als Wirkstoff-Vorläufer von COX-2 Inhibitoren |
US5736151A (en) * | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
US6307047B1 (en) * | 1997-08-22 | 2001-10-23 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
US6395746B1 (en) * | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
US6440964B1 (en) * | 1998-09-30 | 2002-08-27 | Alcon Manufacturing, Ltd. | Compositions and methods for treating ophthalmic and otic infections |
US6509327B1 (en) * | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
AR020660A1 (es) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Composiciones antibioticas para el tratamiento de ojos, oidos y nariz |
US6676930B2 (en) * | 1999-11-28 | 2004-01-13 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
US7064132B2 (en) * | 1999-11-28 | 2006-06-20 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis external |
MXPA02006312A (es) * | 1999-12-23 | 2004-06-21 | Nitromed Inc | Inhibidores de ciclooxigenasa-2 nitrosilatados y nitrosados, composiciones y metodos para utilizarse. |
US20010049366A1 (en) * | 2000-02-09 | 2001-12-06 | Alcon Universal Ltd. | Topical solution formulations containing an antibiotic and a corticosteroid |
WO2001072298A1 (en) * | 2000-03-27 | 2001-10-04 | The General Hospital Corporation | Treatments for immune-mediated ear disorders |
EP2241328A1 (en) * | 2000-05-12 | 2010-10-20 | Immunex Corporation | Interleukin-1 inhibitors in the treatment of diseases |
EP1353664A2 (en) * | 2000-06-08 | 2003-10-22 | The Board Of Regents, The University Of Texas System | Heterocycle derivatives and methods of use for treating anthrax infection |
DE60131537T2 (de) * | 2000-06-22 | 2008-10-23 | Nitromed, Inc., Lexington | Nitrosierte und nitrosylierte taxane, zubereitungen und methoden der verwendung |
US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
-
2004
- 2004-03-05 US US10/795,191 patent/US20040214753A1/en not_active Abandoned
- 2004-03-09 CL CL200400471A patent/CL2004000471A1/es unknown
- 2004-03-10 CA CA002519589A patent/CA2519589A1/en not_active Abandoned
- 2004-03-10 EP EP04719029A patent/EP1608406A1/en not_active Withdrawn
- 2004-03-10 JP JP2006506360A patent/JP2006520778A/ja not_active Abandoned
- 2004-03-10 BR BRPI0408559-0A patent/BRPI0408559A/pt not_active IP Right Cessation
- 2004-03-10 WO PCT/IB2004/000802 patent/WO2004082719A1/en active Application Filing
- 2004-03-10 KR KR1020057017520A patent/KR100765614B1/ko not_active IP Right Cessation
- 2004-03-10 RU RU2005126363/14A patent/RU2321423C2/ru not_active IP Right Cessation
- 2004-03-10 NZ NZ541780A patent/NZ541780A/en unknown
- 2004-03-10 MX MXPA05010019A patent/MXPA05010019A/es not_active Application Discontinuation
- 2004-03-10 AU AU2004222518A patent/AU2004222518A1/en not_active Abandoned
- 2004-03-10 CN CNA2004800075515A patent/CN1761486A/zh active Pending
- 2004-03-18 AR ARP040100904A patent/AR043651A1/es not_active Application Discontinuation
- 2004-03-18 UY UY28236A patent/UY28236A1/es not_active Application Discontinuation
- 2004-03-19 TW TW093107484A patent/TWI265809B/zh not_active IP Right Cessation
-
2005
- 2005-08-16 ZA ZA200506531A patent/ZA200506531B/en unknown
- 2005-09-16 CO CO05094077A patent/CO5611165A2/es not_active Application Discontinuation
- 2005-10-17 NO NO20054777A patent/NO20054777L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TWI265809B (en) | 2006-11-11 |
TW200507852A (en) | 2005-03-01 |
BRPI0408559A (pt) | 2006-03-21 |
KR20050114245A (ko) | 2005-12-05 |
AR043651A1 (es) | 2005-08-03 |
AU2004222518A1 (en) | 2004-09-30 |
UY28236A1 (es) | 2004-11-08 |
NZ541780A (en) | 2008-06-30 |
RU2321423C2 (ru) | 2008-04-10 |
CL2004000471A1 (es) | 2005-04-22 |
KR100765614B1 (ko) | 2007-10-09 |
CN1761486A (zh) | 2006-04-19 |
US20040214753A1 (en) | 2004-10-28 |
MXPA05010019A (es) | 2005-11-17 |
JP2006520778A (ja) | 2006-09-14 |
RU2005126363A (ru) | 2006-05-10 |
CO5611165A2 (es) | 2006-02-28 |
CA2519589A1 (en) | 2004-09-30 |
ZA200506531B (en) | 2006-11-29 |
WO2004082719A1 (en) | 2004-09-30 |
EP1608406A1 (en) | 2005-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054777L (no) | Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelser | |
NO20054260L (no) | Disepergebar formulering av en anti-inflammatorisk forbindelse | |
NO20052306L (no) | Dispergerbare farmasoytiske blandinger. | |
CO5650245A2 (es) | Formulaciones dispersable de un agente anti-inflamatorio | |
NO20065505L (no) | Apparat og fremgangsmate for kirugisk forbedring av vandig vaeskedrenering. | |
EA200800798A1 (ru) | Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха | |
BR0313371A (pt) | Composto, uso de um composto e método de tratamento de doença | |
NO20085158L (no) | Farmasoytiske blandinger av ropinirol samt deres anvendelse | |
BRPI0512311A (pt) | uso de meloxicam em medicina veterinária para o tratamento de doenças inflamatórias dolorosas | |
BRPI0407485A (pt) | utilização de anticorpos anti-receptores de factor crescimento i semelhantes aos anti-insulina | |
DK1317419T3 (da) | Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler | |
NO336678B1 (no) | Anvendelse av ekstraherte botaniske antocyanosider, sanguariner og keleritriner for fremstilling av sammensetninger til munnhygiene | |
BR0206568A (pt) | Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição | |
NO20071354L (no) | anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme. | |
WO2007112453A3 (en) | Methods amd compositions for treating conditions | |
WO2006102438A3 (en) | Methods and compositions for irrigation of mucosal tissues | |
NO20052960L (no) | Anvendelse av dokosahekasensyre som aktivt stoff til behandling av lipodystrofi | |
NO20083784L (no) | Nytt sitratsalt av en indol derivativ og den farmasoytiske bruken derav | |
NO20054320L (no) | Terapeutisk middel mot hemoroidesykdom | |
NO20064196L (no) | Utvortes preparat for behandling av smertefulle hudskader | |
BRPI0412923A (pt) | composição farmacêutica dispersìvel para o tratamento de mastite e de distúrbios óticos | |
MD2516C2 (ro) | Remediu medicamentos antiinflamator, antiseptic şi antifungic sub formă de gel | |
PT1347753E (pt) | Composicao topica e metodo para o tratamento da incontinencia urinaria de stress | |
BR0113055A (pt) | Preparação sólida altamente absorvìvel | |
UA132535U (uk) | Пероральна лікарська форма з відстроченим вивільненням активної речовини |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |